Trial halted early: could a common nausea drug help MG patients tolerate treatment?
NCT ID NCT04226170
Summary
This study aimed to see if adding the anti-nausea drug ondansetron could help people with myasthenia gravis better tolerate the stomach side effects (like nausea and diarrhea) of pyridostigmine, a standard medication. It was a small, short-term trial for adults who either had trouble with these side effects or had stopped the drug because of them. The trial was terminated early after enrolling only two participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Conditions
Explore the condition pages connected to this study.